Determination of tungsten in bulk drug substance and intermediates by ICP-AES and ICP-MS

Citation
Tb. Wang et al., Determination of tungsten in bulk drug substance and intermediates by ICP-AES and ICP-MS, J PHARM B, 19(6), 1999, pp. 937-943
Citations number
16
Categorie Soggetti
Chemistry & Analysis
Journal title
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
ISSN journal
07317085 → ACNP
Volume
19
Issue
6
Year of publication
1999
Pages
937 - 943
Database
ISI
SICI code
0731-7085(199905)19:6<937:DOTIBD>2.0.ZU;2-I
Abstract
A quick and sensitive method has been developed and validated for the deter mination of tungsten in bulk drug substance and intermediates using either Inductively Coupled Plasma Atomic Emission Spectrometry (ICP-AES) or Induct ively Coupled Plasma Mass Spectrometry (ICP-MS). Sample preparation is by d irect dissolution with a 80:20 (v/v) concentrated nitric acid:deionized wat er mixture and avoids labor intensive and potentially hazardous digestion t echniques. Excellent agreement was found between ICP-AES and ICP-MII result s and between Merck results and Microwave Induced Plasma Mass Spectrometry (MIP-MS) results provided by an independent raw material vendor. (C) 1999 E lsevier Science B.V. All rights reserved.